Acadia Pharmaceuticals Inc (ACAD): Shares Outstanding
170.31M
As of 2025-12-31
172.13M
As of 2026-06-30
+1.7%
3-year compound annual growth
+1.3%
5-year compound annual growth
+5.3%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 170.31M | +2.2% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 166.71M | +1.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 164.65M | +1.6% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 162.06M | +0.7% | 2024-02-28, Balance as of period end |
| 2021-12-31 | 161.01M | +0.9% | 2023-02-28, Balance as of period end |
| 2020-12-31 | 159.64M | +2.8% | 2022-03-01, Balance as of period end |
| 2019-12-31 | 155.28M | +7.9% | 2021-02-25, Balance as of period end |
| 2018-12-31 | 143.85M | +15.6% | 2020-02-27, Balance as of period end |
| 2017-12-31 | 124.41M | +2.5% | 2019-02-27, Balance as of period end |
| 2016-12-31 | 121.37M | +19.1% | 2018-02-27, Balance as of period end |
| 2015-12-31 | 101.94M | +1.9% | 2017-02-28, Balance as of period end |
| 2014-12-31 | 100.05M | +9.8% | 2016-02-29, Balance as of period end |
| 2013-12-31 | 91.10M | +24.2% | 2015-02-26, Balance as of period end |
| 2012-12-31 | 73.33M | +38.6% | 2014-02-27, Balance as of period end |
| 2011-12-31 | 52.90M | +34.4% | 2013-03-12, Balance as of period end |
| 2010-12-31 | 39.35M | n/a | 2012-03-06, Balance as of period end |